# US 2005/0221406 A1 · Method, composition and device for treating starch related diseases

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2005/0221406 A1
- Document ID: US20050221406A1
- Status: Published application
- Kind: A1
- Application number: 10/930,538
- Filed: 2004-08-31
- Published: 2005-10-06
- Earliest claimed: 2004-04-05
- Inventors: Tarig Arbab
- Web page: https://patentgrep.com/patent/US20050221406A1

## CPC

- G01N 33/66: involving blood sugars, e.g. galactose
- C12Q 1/26: involving oxidoreductase
- C12Q 1/485: {involving kinase}
- G01N 2400/16: Starch, amylose, amylopectin
- G01N 2800/042: Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The present invention includes a method of diagnosing an insulin resistant mammal including the steps of obtaining one or more samples for testing; and determining the level of starch in the one or more samples, whereby the presence of starch correlates with insulin resistant.

## Claims

### Claim 1

A method of diagnosing an insulin resistant mammal comprising the steps of:
obtaining one or more samples for testing; and
determining the level of starch in the one or more samples, whereby the presence of starch correlates with insulin resistant.

### Claim 2 (depends on 1)

The method of claim 1, wherein the step of testing further comprises contacting the one or more samples with one or more bicarbonates, one or more alkaline agents, one or more hexokinases, one or more oxidases, one or more amylases or combination thereof.

### Claim 3 (depends on 1)

The method of claim 1, wherein the step of testing includes detecting one or more visible wavelengths, one or more IR wavelengths, one or more Near IR wavelengths, one or more UV wavelengths, one or more fluorescence wavelengths, one or more chemiluminescence wavelengths, one or more radiation emissions, one or more FRET emissions, one or more ELISA emissions or combination thereof.

### Claim 4 (depends on 1)

The method of claim 1, wherein the one or more samples are blood, sweat, tears, urine, saliva, cellular fluids, mucus tissues, skin, organs or combination thereof.

### Claim 5

A method of detecting a polysaccharide-based disease comprising the steps of:
isolating a sample from a patient suspected of having the polysaccharide based disease; and
determining the relative level of polysaccharide in the sample.

### Claim 6 (depends on 5)

The method of claim 5, wherein the step of determining the relative level of polysaccharide in the sample comprises the detection of one or more visible wavelengths, one or more IR wavelengths, one or more Near IR wavelengths, one or more UV wavelengths, one or more fluorescence wavelengths, one or more chemiluminescence wavelengths, one or more radiation emissions, one or more FRET emissions, one or more ELISA emissions or combination thereof.

### Claim 7

A method of treating an insulin resistant patient comprising the step of:
isolating a sample from a patient suspected of having the polysaccharide based disease;
determining the relative level of polysaccharide in the sample; and
administering a pharmaceutical formulation to the patient one or more hexokinases, one or more oxidases, one or more amylases or combination thereof.

### Claim 8 (depends on 7)

The method of claim 7, wherein the pharmaceutical formulation comprises one or more enzymes, one or more compounds, one or more solutions, one or more vitamins, one or more minerals or combinations thereof.

### Claim 9 (depends on 7)

The method of claim 7, wherein the pharmaceutical formulation comprises one or more bicarbonates, one or more alkaline agents, one or more hexokinases, one or more oxidases, one or more amylases or combination thereof.

### Claim 10 (depends on 7)

The method of claim 7, wherein the pharmaceutical formulation is an intravenous preparation, a capsule, a tablet, a medicinal syrup, a liquid, a lotion, a spray, an ointment, a cream, a dissolvable tablet, a suppository, an effervescent tablet or combination thereof.

### Claim 11

A diagnostic device comprising:
a sensor that measures the presence of one or more polysaccharides, wherein the sensor contacts a sample suspected of having polysaccharides present.

### Claim 12 (depends on 11)

The diagnostic device of claim 11, wherein the sensor detects one or more visible wavelengths, one or more IR wavelengths, one or more Near IR wavelengths, one or more UV wavelengths, one or more fluorescence wavelengths, one or more chemiluminescence wavelengths, one or more radiation emissions, one or more FRET emissions, one or more ELISA emissions or combination thereof.

### Claim 13 (depends on 11)

The diagnostic device of claim 11, wherein the sample is combined with one or more bicarbonates, one or more hexokinases, one or more oxidases, one or more amylases or combination thereof.

### Claim 14

A method of determining the total sample disaccharide/monosaccharide levels in a patient comprising the step of:
detecting an initial disaccharide/monosaccharide level in a sample;
converting one or more oligosaccharides in the sample into one or more monosaccharides; and
detecting a total disaccharide/monosaccharide level in a sample, whereby the difference between the initial disaccharide/monosaccharide level and the total monosaccharide level is the level of polysaccharides in the sample.

### Claim 15 (depends on 14)

The method of claim 14, wherein the step of converting one or more oligosaccharides to one or more disaccharides or monosaccharides comprises adding one or more bicarbonates, one or more hexokinases, one or more oxidases, one or more amylases or combination thereof to the sample.

### Claim 16

An pharmaceutical formulation in a dosage form for effectively decreasing polysaccharide levels comprising:
one or more agents capable of converting polysaccharides into disaccharides/monosaccharides.

### Claim 17 (depends on 16)

The pharmaceutical formulation of claim 16, wherein the pharmaceutical formulation is an intaravenous preparation, a capsule, a tablet, a medicinal syrup, a liquid, a lotion, a spray, an ointment, a cream, a dissolvable tablet, a suppository, an effervescent tablet or combination thereof.

### Claim 18 (depends on 16)

The pharmaceutical formulation of claim 16, wherein the one or more agents comprise one or more bicarbonates, one or more alkaline agents, one or more hexokinases, one or more oxidases, one or more amylases or combination thereof.

### Claim 20

A method of determining a starch level of an individual comprising the steps of:
applying a reaction solution to a portion of the skin of the individual; and
determining the starch level in the skin with a sensor that measures the product of the reaction solution on the skin.

### Claim 21 (depends on 20)

The diagnostic device of claim 20, wherein the sensor detects one or more visible wavelengths, one or more IR wavelengths, one or more Near IR wavelengths, one or more UV wavelengths, one or more fluorescence wavelengths, one or more chemiluminescence wavelengths, one or more radiation emissions, one or more FRET emissions, one or more ELISA emissions or combination thereof.

### Claim 22 (depends on 20)

The method of claim 20, wherein the reaction solution comprises: iodine, water, an alcohol and a salt.

### Claim 23 (depends on 20)

The method of claim 20, wherein the sensor is portable.

### Claim 24

An enzyme in a dosage form for effectively decreasing polysaccharide levels, comprising:
a therapeutically effective amount of one or more enzymes capable of converting polysaccharides into disaccharides and/or monosaccharides; and
one or more pharmaceutical agents.

### Claim 25 (depends on 24)

The enzyme in a dosage form of claim 24, wherein the one or more enzymes are blended with one or more agents.

### Claim 26 (depends on 24)

The enzyme in a dosage form of claim 24, wherein the one or more enzymes are one or more hexokinases, one or more oxidases, one or more amylases or combination thereof.
